Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RT001 in Amyotrophic Lateral Sclerosis
NCT04762589Phase 2Completed
- Sponsor
- BioJiva LLC
- Start
- Mar 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of RT001 in amyotrophic lateral sclerosis (ALS), sponsored by BioJiva LLC. Started Mar 2021; status: completed.
02
Drugs
RT001
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT04762589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04762589.